EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Human Brain Deuterium Metabolic Imaging at 7 T : Impact of Different [6,6′‐ 2 H 2 ]Glucose Doses

Narjes Ahmadian iD, Maaike M Konig, Sigrid Otto, Kiki Tesselaar, Pieter van Eijsden, Mark Gosselink, Ayhan Gursan, Dennis W Klomp, Jeanine J Prompers, Evita C Wiegers

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Narjes Ahmadian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Brain, Glucose, Deuterium, Magnetic Resonance Imaging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Innovation Council (EIC), European commision.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deuterium metabolic imaging (DMI) is an innovative, noninvasive metabolic MR imaging method conducted after administration of 2 H‐labeled substrates. DMI after [6,6′‐ 2 H 2 ]glucose consumption has been used to investigate brain metabolic processes, but the impact of different [6,6′‐ 2 H 2 ]glucose doses on DMI brain data is not well known.

Purpose

To investigate three different [6,6′‐ 2 H 2 ]glucose doses for DMI in the human brain at 7 T. Study Type Prospective. Population Six healthy participants (age: 28 ± 8 years, male/female: 3/3). Field Strength/Sequence 7 T, 3D 2 H free‐induction‐decay (FID)‐magnetic resonance spectroscopic imaging (MRSI) sequence. Assessment Three subjects received two different doses (0.25 g/kg, 0.50 g/kg or 0.75 g/kg body weight) of [6,6′‐ 2 H 2 ]glucose on two occasions and underwent consecutive 2 H‐MRSI scans for 120 minutes. Blood was sampled every 10 minutes during the scan, to determine plasma glucose levels and plasma 2 H‐Glucose atom percent excess (APE) (part‐1). Three subjects underwent the same protocol once after receiving 0.50 g/kg [6,6′‐ 2 H 2 ]glucose (part‐2). Statistical Test Mean plasma 2 H‐Glucose APE and glucose plasma concentrations were compared using one‐way ANOVA. Brain 2 H‐Glc and brain 2 H‐Glx (part‐1) were analyzed with a two‐level Linear Mixed Model. In part‐2, a General Linear Model was used to compare brain metabolite signals. Statistical significance was set at P < 0.05.

Results

Between 60 and 100 minutes after ingesting [6,6′‐ 2 H 2 ]glucose, plasma 2 H‐Glc APE did not differ between 0.50 g/kg and 0.75 g/kg doses ( P = 0.961), but was significantly lower for 0.25 g/kg. Time and doses significantly affected brain 2 H‐Glucose levels (estimate ± standard error [SE]: 0.89 ± 0.01, 1.09 ± 0.01, and 1.27 ± 0.01, for 0.25 g/kg, 0.50 g/kg, and 0.75 g/kg, respectively) and brain 2 H‐Glutamate/Glutamine levels (estimate ± SE: 1.91 ± 0.03, 2.27 ± 0.03, and 2.46 ± 0.03, for 0.25 g/kg, 0.50 g/kg, and 0.75 g/kg, respectively). Plasma 2 H‐Glc APE, brain 2 H‐Glc, and brain 2 H‐Glx levels were comparable among subjects receiving 0.50 g/kg [6,6′‐ 2 H 2 ]glucose. Data Conclusion Brain 2 H‐Glucose and brain 2 H‐Glutamate/Glutamine showed to be [6,6′‐ 2 H 2 ]glucose dose dependent. A dose of 0.50 g/kg demonstrated comparable, and well‐detectable, 2 H‐Glucose and 2 H‐Glutamate/Glutamine signals in the brain. Evidence Level 1 Technical Efficacy Stage 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainGlucoseDeuteriumMagnetic Resonance ImagingHumansFemaleMaleAdultProspective StudiesMagnetic Resonance SpectroscopyDose-Response Relationship, DrugBlood GlucoseYoung Adult

Stichwörter der Autor:innen

7 T MRIbrain metabolismdeuterium metabolic imaging

Substanzen

GlucoseDeuteriumBlood Glucose

Autor:innen und Institutionen

  • Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands.
  • CTI Lab Support, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Neurosurgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.

ORCID-Profile: Narjes Ahmadian

Förderung

  • European Innovation Council (EIC), European commision

Zitieren

APA

Ahmadian, N., Konig, M. M., Otto, S., Tesselaar, K., van Eijsden, P., Gosselink, M., Gursan, A., Klomp, D. W., Prompers, J. J., & Wiegers, E. C. (2025). Human Brain Deuterium Metabolic Imaging at 7 T : Impact of Different [6,6′‐ 2 H 2 ]Glucose Doses. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29532

Vancouver

Ahmadian N, Konig MM, Otto S, Tesselaar K, van Eijsden P, Gosselink M, et al. Human Brain Deuterium Metabolic Imaging at 7 T : Impact of Different [6,6′‐ 2 H 2 ]Glucose Doses. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29532

BibTeX
@article{Ahmadian2025,
  author = {Ahmadian, Narjes and Konig, Maaike M and Otto, Sigrid and Tesselaar, Kiki and van Eijsden, Pieter and Gosselink, Mark and Gursan, Ayhan and Klomp, Dennis W and Prompers, Jeanine J and Wiegers, Evita C},
  title = {Human Brain Deuterium Metabolic Imaging at 7 T : Impact of Different [6,6′‐ 2 H 2 ]Glucose Doses},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29532}
}
Kostenlos starten →